GlycA, a novel inflammatory marker, is associated with subclinical coronary disease

被引:29
|
作者
Tibuakuu, Martin [1 ,2 ]
Fashanu, Oluwaseun E. [1 ]
Zhao, Di [3 ]
Otvos, James D. [4 ]
Brown, Todd T. [5 ]
Haberlen, Sabina A. [3 ]
Guallar, Eliseo [3 ]
Budoff, Matthew J. [6 ]
Palella, Frank J., Jr. [7 ]
Martinson, Jeremy J. [8 ]
Akinkuolie, Akintunde O. [9 ,10 ]
Mora, Samia [9 ]
Post, Wendy S. [1 ,3 ]
Michos, Erin D. [1 ,3 ]
机构
[1] Johns Hopkins Sch Med, Ciccarone Ctr Prevent Heart Dis, Baltimore, MD USA
[2] St Lukes Hosp, Dept Med, Chesterfield, MO USA
[3] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21287 USA
[4] LabCorp, Morrisville, NC USA
[5] Johns Hopkins Sch Med, Div Endocrinol Diabet & Metab, Baltimore, MD USA
[6] Los Angeles Biomed Res Inst Harbor UCLA, Los Angeles, CA USA
[7] Northwestern Univ, Feinberg Sch Med, Div Infect Dis, Chicago, IL 60611 USA
[8] Univ Pittsburgh, Dept Infect Dis & Microbiol, Pittsburgh, PA USA
[9] Harvard Med Sch, Brigham & Womens Hosp, Ctr Lipid Metabol, Boston, MA 02115 USA
[10] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA
关键词
cardiac computed tomography; coronary artery calcium; coronary atherosclerosis; GlycA; HIV infection; inflammation; MULTICENTER AIDS COHORT; C-REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE; COMPUTED-TOMOGRAPHY; PREDICTIVE-VALUE; HIV-INFECTION; RISK; ATHEROSCLEROSIS; BIOMARKER; EVENTS;
D O I
10.1097/QAD.0000000000002079
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: GlycA, a novel NMR biomarker of inflammation, has been associated with incident cardiovascular disease (CVD) in the general population, but its association with CVD among HIV-infected individuals is unknown. We examined the associations between GlycA and subclinical coronary plaque among HIV-infected and HIV-uninfected men participating in Multicenter AIDS Cohort Study (MACS). Design: Cross-sectional analysis of 935 men with plasma measurement of GlycA and noncontrast cardiac computed tomography (CT) and/or coronary CT angiography. Methods: We used multivariable Poisson and linear regression to assess associations of GlycA with prevalent coronary atherosclerosis and plaque extent, respectively. Results: Mean +/- SD age was 54 +/- 7 years; 31% were black; 63% HIV-infected. GlycA levels were higher in HIV-infected compared with HIV-uninfected men (397 +/- 68 vs. 380 +/- 60 mu mol/l, P = 0.0001) and higher for men with detectable viral load vs. undetectable (413 +/- 79 vs. 393 +/- 65 mu mol/l, P = 0.004). After adjusting for HIV serostatus, demographic and CVD risk factors, every 1SD increment in GlycA level was associated with a higher prevalence of coronary artery calcium (CAC > 0) [prevalence ratio 1.09 (95% CI 1.03-1.15)] and coronary stenosis at least 50% [1.20 (1.02-1.41)]. These associations were not significantly altered after adjusting for traditional inflammatory biomarkers or differ by HIV serostatus. Among men with plaque, GlycA was positively associated with the extent of CAC and total plaque. Conclusion: HIV infection was associated with higher GlycA levels. In both HIV-infected and HIV-uninfected individuals, GlycA was significantly associated with several measures of subclinical coronary atherosclerosis, independent of other CVD risk factors and inflammatory biomarkers. These findings suggest the potential role of GlycA in CVD risk stratification among HIV patients. Copyright (C) 2018 Wolters Kluwer Health, Inc. All rights reserved.
引用
收藏
页码:547 / 557
页数:11
相关论文
共 50 条
  • [1] GlycA, a Novel Inflammatory Marker, and Subclinical Coronary Atherosclerosis in the Multicenter AIDS Cohort Study (MACS)
    Fashanu, Oluwaseun E.
    Tibuakuu, Martin
    Zhao, Di
    Otvos, James D.
    Brown, Todd T.
    Haberlen, Sabina A.
    Guallar, Eliseo
    Budoff, Matthew J.
    Palella, Frank J.
    Martinson, Jeremy J.
    Akinkuolie, Akintunde O.
    Mora, Samia
    Post, Wendy S.
    Michos, Erin D.
    CIRCULATION, 2018, 137
  • [2] Utility of a novel inflammatory marker, GlycA, for assessment of rheumatoid arthritis disease activity and coronary atherosclerosis
    Ormseth, Michelle J.
    Chung, Cecilia P.
    Oeser, Annette M.
    Connelly, Margery A.
    Sokka, Tuulikki
    Raggi, Paolo
    Solus, Joseph F.
    Otvos, James D.
    Stein, C. Michael
    ARTHRITIS RESEARCH & THERAPY, 2015, 17
  • [3] UTILITY OF A NOVEL INFLAMMATORY MARKER, GLYCA, FOR ASSESSMENT OF RHEUMATOID ARTHRITIS DISEASE ACTIVITY AND CORONARY ATHEROSCLEROSIS
    Ormseth, M.
    Chung, C.
    Oeser, A.
    Connelly, M.
    Sokka, T.
    Raggi, P.
    Solus, J.
    Otvos, J.
    Stein, C. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 452 - 452
  • [4] Utility of a novel inflammatory marker, GlycA, for assessment of rheumatoid arthritis disease activity and coronary atherosclerosis
    Michelle J. Ormseth
    Cecilia P. Chung
    Annette M. Oeser
    Margery A. Connelly
    Tuulikki Sokka
    Paolo Raggi
    Joseph F. Solus
    James D. Otvos
    C. Michael Stein
    Arthritis Research & Therapy, 17
  • [5] Utility of Glyca, a Novel Inflammatory Marker, for Assessment of Rheumatoid Arthritis Disease Activity.
    Ormseth, Michelle
    Chung, Cecilia P.
    Solus, Joseph F.
    Oeser, Annette M.
    Connelly, Margery A.
    Otvos, Jim
    Stein, C. Michael
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S837 - S837
  • [6] GlycA Is a Novel Biomarker of Inflammation and Subclinical Cardiovascular Disease in Psoriasis
    Joshi, Aditya A.
    Lerman, Joseph B.
    Aberra, Tsion M.
    Afshar, Mehdi
    Teague, Heather L.
    Rodante, Justin A.
    Krishnamoorthy, Parasuram
    Ng, Qimin
    Aridi, Tarek Z.
    Salahuddin, Taufiq
    Natarajan, Balaji
    Lockshin, Benjamin N.
    Ahlman, Mark A.
    Chen, Marcus Y.
    Rader, Daniel J.
    Reilly, Muredach P.
    Remaley, Alan T.
    Bluemke, David A.
    Playford, Martin P.
    Gelfand, Joel M.
    Mehta, Nehal N.
    CIRCULATION RESEARCH, 2016, 119 (11) : 1242 - +
  • [7] GlycA: A Novel Marker of Inflammation and Potential Link Between Obesity and Cardiovascular Disease
    Riggs, Kayla A.
    Rocha, Natalia A.
    Patel, Kershaw, V
    Khera, Amit
    Ayers, Colby R.
    Neeland, Ian J.
    Rohatgi, Anand
    CIRCULATION, 2018, 138
  • [8] Impaired HDL Metabolism Links GlycA, A Novel Inflammatory Marker, with Incident Cardiovascular Events
    Riggs, Kayla A.
    Joshi, Parag H.
    Khera, Amit
    Singh, Kavisha
    Akinmolayemi, Oludamilola
    Ayers, Colby R.
    Rohatgi, Anand
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (12)
  • [9] INFLAMMATORY MARKERS ASSOCIATED WITH SUBCLINICAL CORONARY ARTERY DISEASE IN HIV INFECTED PATIENTS
    Bahrami, Hossein
    Budoff, Matthew
    Palella, Frank
    Witt, Mallory
    Kingsley, Lawrence
    Jocobson, Lisa
    Post, Wendy
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A1158 - A1158
  • [10] EN-RAGE: A Novel Inflammatory Marker for Coronary Heart Disease
    Ligthart, Symen
    Sedaghat, Sanaz
    Ikram, M. A.
    Hofman, Albert
    Franco, Oscar H.
    Dehghan, Abbas
    CIRCULATION, 2014, 130